Study of the Correlation Between Preoperative Precise Biometrics, Spatial Assessment and Postoperative Visual Quality in Cataract Patients

This study summarizes the experience of precision treatment and postoperative management of various types of cataract, and intend to further improve the quality of Clinical Cataract diagnosis and treatment.

Study Overview

Status

Recruiting

Detailed Description

Based on the existing cataract surgery methods, through prospective follow-up study, this study summarizes the experience of precision treatment and postoperative management of various types of cataract, and intends to further improve the quality of Clinical Cataract diagnosis and treatment.

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Hangzhou, China
        • Recruiting
        • Second Affiliated Hospital, Zhejiang University School of Medicine
        • Contact:
          • Wen Xu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 90 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Cataract surgery was performed in ophthalmic hospital affiliated to Medical College of Zhejiang University

Description

Inclusion Criteria:

  • Patients with monocular or binocular cataract, lens opacity or abnormal position, need surgery

Exclusion Criteria:

  • The history of systemic diseases and medication affecting vision, diabetic patients with systemic conditions complicated with retinopathy, uncontrolled blood glucose, severe eye diseases, eye trauma, eye surgery, severe dry eye and ocular surface diseases, strabismus and amblyopia were identified

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Senile cataract
Traumatic cataract
Congenital cataract
Lens dislocation group
Complicated cataract

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Best Corrected Visual Acuity
Time Frame: 1 week postoperatively
The BCVA was measured by the same optometrist at each visit
1 week postoperatively
Best Corrected Visual Acuity
Time Frame: 1 month postoperatively
The BCVA was measured by the same optometrist at each visit
1 month postoperatively
Best Corrected Visual Acuity
Time Frame: 3 months postoperatively
The BCVA was measured by the same optometrist at each visit
3 months postoperatively
Uncorrected distance visual acuity
Time Frame: 1 week postoperatively
The UCVA was measured by the same optometrist at each visit
1 week postoperatively
Uncorrected distance visual acuity
Time Frame: 1 month postoperatively
The UCVA was measured by the same optometrist at each visit
1 month postoperatively
Uncorrected distance visual acuity
Time Frame: 3 months postoperatively
The UCVA was measured by the same optometrist at each visit
3 months postoperatively
Intraocular pressure
Time Frame: 1 week postoperatively
Intraocular pressure measured using non-contact tonometer
1 week postoperatively
Intraocular pressure
Time Frame: 1 month postoperatively
Intraocular pressure measured using non-contact tonometer
1 month postoperatively
Intraocular pressure
Time Frame: 3 months postoperatively
Intraocular pressure measured using non-contact tonometer
3 months postoperatively
Tear Breakup Time
Time Frame: 1 week postoperatively
Tear Breakup Time was performed to assess tear film stability
1 week postoperatively
Tear Breakup Time
Time Frame: 1 month postoperatively
Tear Breakup Time was performed to assess tear film stability
1 month postoperatively
Tear Breakup Time
Time Frame: 3 months postoperatively
Tear Breakup Time was performed to assess tear film stability
3 months postoperatively
Endothelial cell density
Time Frame: 1 month postoperatively
Endothelial cell density was measured by specular microscopy
1 month postoperatively
Contrast sensitivity
Time Frame: 1 month postoperatively
The contrast sensitivity was recorded in dark environment, glare dark environment, light environment, glare light environment
1 month postoperatively
Defocusing curve
Time Frame: 1 month postoperatively
From +2.00d to -4.00d, 13 different diopter states were obtained by decreasing the spherical lens degree of +0.50d, and the defocus curve was formed
1 month postoperatively
Stereoscopic vision
Time Frame: 1 month postoperatively
The binocular diopter was not corrected. The stereopsis test card was used to record the arc seconds of random points, animals and circles
1 month postoperatively
Glasses usage frequency
Time Frame: 3 months postoperatively
The frequency of long / medium / short distance use of corrective glasses was scored as 0%, 25%, 50%, 75% and 100%
3 months postoperatively
Optical visual quality questionnaire
Time Frame: 3 months postoperatively
Glare, halos, starburst and other visual quality problems were graded as mild(1 score), moderate(2 score) and severe(3 score)
3 months postoperatively
Visual satisfaction
Time Frame: 3 months postoperatively
The visual acuity satisfaction of distance / middle / near distance was scored from 0 (totally dissatisfied) to 10 (totally satisfied)
3 months postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 20, 2021

Primary Completion (Anticipated)

December 31, 2026

Study Completion (Anticipated)

December 31, 2026

Study Registration Dates

First Submitted

April 2, 2021

First Submitted That Met QC Criteria

April 4, 2021

First Posted (Actual)

April 6, 2021

Study Record Updates

Last Update Posted (Actual)

May 10, 2021

Last Update Submitted That Met QC Criteria

May 6, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • xuwen2021-0189

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Recruitment of Participants

Subscribe